Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: In vivo and in vitro evidence

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 1, 2014, Pages 88-96

  Rancoule, Chloé ^a,b   Viaud, Manon ^a,b   Gres, Sandra ^a,b   Viguerie, Nathalie ^a,b   Decaunes, Pauline ^a,b   Bouloumié, Anne ^a,b   Langin, Dominique ^a,b,c   Bascands, Jean Loup ^a,b   Valet, Philippe ^a,b   Saulnier Blache, Jean Sébastien ^a,b  

^a INSERM   (France)

^b Université de Toulouse   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Adipose tissue; Fibrosis; Lysophosphatidic acid

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; AUTOTAXIN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 16425; LIFICIGUAT; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; EXPLANT; FIBROSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; OBESITY; PRIMARY CULTURE; PRIORITY JOURNAL; PROFIBROTIC ACTIVITY; PROTEIN EXPRESSION; TREATMENT DURATION;

MUS;

EID: 84886158605     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.10.003     Document Type: Article

References (70)

1. E.C. Mariman, and P. Wang Adipocyte extracellular matrix composition, dynamics and role in obesity Cell. Mol. Life Sci. 67 2010 1277 1292
2. C.S. Tam, J. Tordjman, A. Divoux, L.A. Baur, and K. Clement Adipose tissue remodeling in children: the link between collagen deposition and age-related adipocyte growth J. Clin. Endocrinol. Metab. 97 2012 1320 1327
3. M. Spencer, A. Yao-Borengasser, R. Unal, N. Rasouli, C.M. Gurley, B. Zhu, C.A. Peterson, and P.A. Kern Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation Am. J. Physiol. Endocrinol. Metab. 299 2010 E1016 E1027
4. A. Divoux, J. Tordjman, D. Lacasa, N. Veyrie, D. Hugol, A. Aissat, A. Basdevant, M. Guerre-Millo, C. Poitou, J.D. Zucker, P. Bedossa, and K. Clement Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss Diabetes 59 2010 2817 2825
5. M. Pasarica, B. Gowronska-Kozak, D. Burk, I. Remedios, D. Hymel, J. Gimble, E. Ravussin, G.A. Bray, and S.R. Smith Adipose tissue collagen VI in obesity J. Clin. Endocrinol. Metab. 94 2009 5155 5162
6. T. Khan, E.S. Muise, P. Iyengar, Z.V. Wang, M. Chandalia, N. Abate, B.B. Zhang, P. Bonaldo, S. Chua, and P.E. Scherer Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI Mol. Cell. Biol. 29 2009 1575 1591
7. J. Huber, M. Loffler, M. Bilban, M. Reimers, A. Kadl, J. Todoric, M. Zeyda, R. Geyeregger, M. Schreiner, T. Weichhart, N. Leitinger, W. Waldhausl, and T.M. Stulnig Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids Int. J. Obes. 31 2007 1004 1013 (Pubitemid 46844776)
8. H.R. Lijnen, E. Maquoi, P. Holvoet, A. Mertens, F. Lupu, P. Morange, M.C. Alessi, and I. Juhan-Vague Adipose tissue expression of gelatinases in mouse models of obesity Thromb. Haemost. 85 2001 1111 1116 (Pubitemid 32573768)
9. M. Keophiphath, V. Achard, C. Henegar, C. Rouault, K. Clement, and D. Lacasa Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes Mol. Endocrinol. 23 2009 11 24
10. V.J. Adapala, S.A. Adedokun, R.V. Considine, and K.M. Ajuwon Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance J. Nutr. Biochem. 23 2012 567 572
11. N. Halberg, T. Khan, M.E. Trujillo, I. Wernstedt-Asterholm, A.D. Attie, S. Sherwani, Z.V. Wang, S. Landskroner-Eiger, S. Dineen, U.J. Magalang, R.A. Brekken, and P.E. Scherer Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue Mol. Cell. Biol. 29 2009 4467 4483
12. K.Y. Lee, S. Gesta, J. Boucher, X.L. Wang, and C.R. Kahn The differential role of Hif1beta/Arnt and the hypoxic response in adipose function, fibrosis, and inflammation Cell Metab. 14 2011 491 503
13. C. Jiang, A. Qu, T. Matsubara, T. Chanturiya, W. Jou, O. Gavrilova, Y.M. Shah, and F.J. Gonzalez Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice Diabetes 60 2011 2484 2495
14. K. Sun, N. Halberg, M. Khan, U.J. Magalang, and P.E. Scherer Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction Mol. Cell. Biol. 33 2013 904 917
15. T. Mutoh, R. Rivera, and J. Chun Insights into the pharmacological relevance of lysophospholipid receptors Br. J. Pharmacol. 165 2012 829 844
16. P. Valet, C. Pages, O. Jeanneton, D. Daviaud, P. Barbe, M. Record, J.S. Saulnier-Blache, and M. Lafontan Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth J. Clin. Invest. 101 1998 1431 1438 (Pubitemid 28166841)
17. S. Gesta, M.F. Simon, A. Rey, D. Sibrac, A. Girard, M. Lafontan, P. Valet, and J.S. Saulnier-Blache Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis J. Lipid Res. 43 2002 904 910 (Pubitemid 34602612)
18. G. Ferry, E. Tellier, A. Try, S. Gres, I. Naime, M.F. Simon, M. Rodriguez, J. Boucher, I. Tack, S. Gesta, P. Chomarat, M. Dieu, M. Raes, J.P. Galizzi, P. Valet, J.A. Boutin, and J.S. Saulnier-Blache Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity J. Biol. Chem. 278 2003 18162 18169 (Pubitemid 36799431)
19. J.P. Pradere, E. Tarnus, S. Gres, P. Valet, and J.S. Saulnier-Blache Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase Biochim. Biophys. Acta 1771 2007 93 102 (Pubitemid 46091769)
20. R. Dusaulcy, C. Rancoule, S. Gres, E. Wanecq, A. Colom, C. Guigne, L.A. van Meeteren, W.H. Moolenaar, P. Valet, and J.S. Saulnier-Blache Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid J. Lipid Res. 52 2011 1247 1255
21. J. Boucher, D. Quilliot, J.P. Praderes, M.F. Simon, S. Gres, C. Guigne, D. Prevot, G. Ferry, J.A. Boutin, C. Carpene, P. Valet, and J.S. Saulnier-Blache Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression Diabetologia 48 2005 569 577 (Pubitemid 40487305)
22. C. Rancoule, R. Dusaulcy, K. Treguer, S. Gres, C. Guigne, D. Quilliot, P. Valet, and J.S. Saulnier-Blache Depot-specific regulation of autotaxin with obesity in human adipose tissue J. Physiol. Biochem. 68 2012 635 644
23. C. Rancoule, C. Attane, S. Gres, A. Fournel, R. Dusaulcy, C. Bertrand, C. Vinel, K. Treguer, M. Prentki, P. Valet, and J.S. Saulnier-Blache Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice Diabetologia 56 2013 1394 1402
24. K. Kano, N. Arima, M. Ohgami, and J. Aoki LPA and its analogs-attractive tools for elucidation of LPA biology and drug development Curr. Med. Chem. 15 2008 2122 2131
25. H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D.S. Im, H. Nochi, K. Tamoto, H. Tomura, and F. Okajima Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64 2003 994 1005 (Pubitemid 37153068)
26. A. Boucharaba, C.M. Serre, J. Guglielmi, J.C. Bordet, P. Clezardin, and O. Peyruchaud The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases Proc. Natl. Acad. Sci. U. S. A. 103 2006 9643 9648 (Pubitemid 43955878)
27. J.P. Pradere, J. Klein, S. Gres, C. Guigne, E. Neau, P. Valet, D. Calise, J. Chun, J.L. Bascands, J.S. Saulnier-Blache, and J.P. Schanstra LPA1 receptor activation promotes renal interstitial fibrosis J. Am. Soc. Nephrol. 18 2007 3110 3118 (Pubitemid 350223970)
28. A.M. Tager, P. LaCamera, B.S. Shea, G.S. Campanella, M. Selman, Z. Zhao, V. Polosukhin, J. Wain, B.A. Karimi-Shah, N.D. Kim, W.K. Hart, A. Pardo, T.S. Blackwell, Y. Xu, J. Chun, and A.D. Luster The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak Nat. Med. 14 2008 45 54
29. H. Ikeda, Y. Yatomi, M. Yanase, H. Satoh, A. Nishihara, M. Kawabata, and K. Fujiwara Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture Biochem. Biophys. Res. Commun. 248 1998 436 440 (Pubitemid 28386442)
30. N. Sakai, J. Chun, J.S. Duffield, T. Wada, A.D. Luster, and A.M. Tager LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation FASEB J. 27 2013 1830 1846
31. F.V. Castelino, J. Seiders, G. Bain, S.F. Brooks, C.D. King, J.S. Swaney, D.S. Lorrain, J. Chun, A.D. Luster, and A.M. Tager Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma Arthritis Rheum. 63 2011 1405 1415
32. A.M. Abu El-Asrar, L. Missotten, and K. Geboes Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes Acta Ophthalmol. 90 2012 e84 e89
33. H. Tan, S. Biechler, L. Junor, M.J. Yost, D. Dean, J. Li, J.D. Potts, and R.L. Goodwin Fluid flow forces and rhoA regulate fibrous development of the atrioventricular valves Dev. Biol. 374 2013 345 356
34. C. Rancoule, J.P. Pradere, J. Gonzalez, J. Klein, P. Valet, J.L. Bascands, J.P. Schanstra, and J.S. Saulnier-Blache Lysophosphatidic acid-1-receptor targeting agents for fibrosis Expert Opin. Investig. Drugs 20 2011 657 667
35. I. Boucher, W. Yu, S. Beaudry, H. Negoro, M. Tran, M.R. Pollak, J.M. Henderson, and B.M. Denker Galpha12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis Lab. Invest. 92 2012 662 675
36. H. Ikeda, K. Nagashima, M. Yanase, T. Tomiya, M. Arai, Y. Inoue, K. Tejima, T. Nishikawa, M. Omata, S. Kimura, and K. Fujiwara Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G880 G886
37. X. Gan, J. Wang, C. Wang, E. Sommer, T. Kozasa, S. Srinivasula, D. Alessi, S. Offermanns, M.I. Simon, and D. Wu PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of Galpha12 Nat. Cell Biol. 14 2012 686 696
38. A. Hahn, J. Heusinger-Ribeiro, T. Lanz, S. Zenkel, and M. Goppelt-Struebe Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton J. Biol. Chem. 275 2000 37429 37435 (Pubitemid 32004847)
39. M.Y. Xu, J. Porte, A.J. Knox, P.H. Weinreb, T.M. Maher, S.M. Violette, R.J. McAnulty, D. Sheppard, and G. Jenkins Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q) Am. J. Pathol. 174 2009 1264 1279
40. C. Rancoule, R. Dusaulcy, K. Treguer, S. Gres, C. Attane, and J.S. Saulnier-Blache Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis Biochimie 2013 (doi:pii: S0300-9084(13)00128-4)
41. S. Gesta, K. Lolmede, D. Daviaud, M. Berlan, A. Bouloumie, M. Lafontan, P. Valet, and J.S. Saulnier-Blache Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression Horm. Metab. Res. 35 2003 158 163 (Pubitemid 36577857)
42. S. Yoshina, A. Tanaka, and S.C. Kuo Studies on heterocyclic compounds. XXXIV. Synthesis of furo[3,2-c]pyrazole derivatives. (2). Electrophilic substitution of 1,3-diphenylfuro[3,2-c]pyrazole (author's transl) Yakugaku Zasshi 98 1978 204 209 (Pubitemid 8288960)
43. E.J. Yeo, Y.S. Chun, Y.S. Cho, J. Kim, J.C. Lee, M.S. Kim, and J.W. Park YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1 J. Natl. Cancer Inst. 95 2003 516 525 (Pubitemid 36511622)
44. J.S. Saulnier-Blache, A. Girard, M.F. Simon, M. Lafontan, and P. Valet A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification J. Lipid Res. 41 2000 1947 1951 (Pubitemid 32038989)
45. A. Sahai, P. Malladi, X. Pan, R. Paul, H. Melin-Aldana, R.M. Green, and P.F. Whitington Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 G1035 G1043
46. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
47. M.F. Simon, D. Daviaud, J.P. Pradere, S. Gres, C. Guigne, M. Wabitsch, J. Chun, P. Valet, and J.S. Saulnier-Blache Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2 J. Biol. Chem. 280 2005 14656 14662 (Pubitemid 40562811)
48. E. Klimcakova, B. Roussel, Z. Kovacova, M. Kovacikova, M. Siklova-Vitkova, M. Combes, J. Hejnova, P. Decaunes, J.J. Maoret, T. Vedral, N. Viguerie, V. Bourlier, A. Bouloumie, V. Stich, and D. Langin Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat Diabetologia 54 2011 876 887
49. C. Sengenes, K. Lolmede, A. Zakaroff-Girard, R. Busse, and A. Bouloumie Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells J. Cell. Physiol. 205 2005 114 122 (Pubitemid 41262857)
50. A. Miranville, C. Heeschen, C. Sengenes, C.A. Curat, R. Busse, and A. Bouloumie Improvement of postnatal neovascularization by human adipose tissue-derived stem cells Circulation 110 2004 349 355 (Pubitemid 38955505)
51. V. Bourlier, C. Sengenes, A. Zakaroff-Girard, P. Decaunes, B. Wdziekonski, J. Galitzky, P. Villageois, D. Esteve, P. Chiotasso, C. Dani, and A. Bouloumie TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages PLoS One 7 2012 e31274
52. J. Lee, S.Y. Park, E.K. Lee, C.G. Park, H.C. Chung, S.Y. Rha, Y.K. Kim, G.U. Bae, B.K. Kim, J.W. Han, and H.Y. Lee Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression Clin. Cancer Res. 12 2006 6351 6358 (Pubitemid 44799704)
53. K. Yang, D. Zheng, X. Deng, L. Bai, Y. Xu, and Y.S. Cong Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway J. Cell. Biochem. 105 2008 1194 1201
54. F. Gao, A. Chattopadhyay, M. Navab, V. Grijalva, F. Su, A.M. Fogelman, S.T. Reddy, and R. Farias-Eisner Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1alpha in human ovarian cancer cell lines and a mouse ovarian cancer model J. Pharmacol. Exp. Ther. 342 2012 255 262
55. A. Divoux, and K. Clement Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue Obes. Rev. 12 2011 e494 e503
56. L.B. Lopes, E.J. Furnish, P. Komalavilas, C.R. Flynn, P. Ashby, A. Hansen, D.P. Ly, G.P. Yang, M.T. Longaker, A. Panitch, and C.M. Brophy Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts J. Invest. Dermatol. 129 2009 590 598
57. T.A. Wynn Cellular and molecular mechanisms of fibrosis J. Pathol. 214 2008 199 210 (Pubitemid 351160157)
58. M. Funke, Z. Zhao, Y. Xu, J. Chun, and A.M. Tager The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury Am. J. Respir. Cell Mol. Biol. 46 2012 355 364
59. Y. Qian, M. Hamilton, A. Sidduri, S. Gabriel, Y. Ren, R. Peng, R. Kondru, A. Narayanan, T. Truitt, R. Hamid, Y. Chen, L. Zhang, A.J. Fretland, R.A. Sanchez, K.C. Chang, M. Lucas, R.C. Schoenfeld, D. Laine, M.E. Fuentes, C.S. Stevenson, and D.C. Budd Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts J. Med. Chem. 55 2012 7920 7939
60. J.S. Swaney, C. Chapman, L.D. Correa, K.J. Stebbins, R.A. Bundey, P.C. Prodanovich, P. Fagan, C.S. Baccei, A.M. Santini, J.H. Hutchinson, T.J. Seiders, T.A. Parr, P. Prasit, J.F. Evans, and D.S. Lorrain A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model Br. J. Pharmacol. 160 2010 1699 1713
61. J.S. Swaney, C. Chapman, L.D. Correa, K.J. Stebbins, A.R. Broadhead, G. Bain, A.M. Santini, J. Darlington, C.D. King, C.S. Baccei, C. Lee, T.A. Parr, J.R. Roppe, T.J. Seiders, J. Ziff, P. Prasit, J.H. Hutchinson, J.F. Evans, and D.S. Lorrain Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist J. Pharmacol. Exp. Ther. 336 2011 693 700
62. N. Watanabe, H. Ikeda, K. Nakamura, R. Ohkawa, Y. Kume, J. Aoki, K. Hama, S. Okudaira, M. Tanaka, T. Tomiya, M. Yanase, K. Tejima, T. Nishikawa, M. Arai, H. Arai, M. Omata, K. Fujiwara, and Y. Yatomi Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C J. Clin. Gastroenterol. 41 2007 616 623 (Pubitemid 46956520)
63. A.B. Cooper, J. Wu, D. Lu, and M.A. Maluccio Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J. Gastrointest. Surg. 11 2007 1628 1634 (discussion 1634-1625)
64. N. Watanabe, H. Ikeda, K. Nakamura, R. Ohkawa, Y. Kume, T. Tomiya, K. Tejima, T. Nishikawa, M. Arai, M. Yanase, J. Aoki, H. Arai, M. Omata, K. Fujiwara, and Y. Yatomi Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity Life Sci. 81 2007 1009 1015 (Pubitemid 47386006)
65. M. El-Batch, W. Ibrahim, and S. Said Effect of histidine on autotaxin activity in experimentally induced liver fibrosis J. Biochem. Mol. Toxicol. 25 2011 143 150
66. H. Nakagawa, H. Ikeda, K. Nakamura, R. Ohkawa, R. Masuzaki, R. Tateishi, H. Yoshida, N. Watanabe, K. Tejima, Y. Kume, T. Iwai, A. Suzuki, T. Tomiya, Y. Inoue, T. Nishikawa, N. Ohtomo, Y. Tanoue, M. Omata, K. Igarashi, J. Aoki, K. Koike, and Y. Yatomi Autotaxin as a novel serum marker of liver fibrosis Clin. Chim. Acta 412 2011 1201 1206
67. F.N. Ko, C.C. Wu, S.C. Kuo, F.Y. Lee, and C.M. Teng YC-1, a novel activator of platelet guanylate cyclase Blood 84 1994 4226 4233
68. S.Y. Park, K.J. Jeong, J. Lee, D.S. Yoon, W.S. Choi, Y.K. Kim, J.W. Han, Y.M. Kim, B.K. Kim, and H.Y. Lee Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol Cancer Lett. 258 2007 63 69 (Pubitemid 47600493)
69. P. Subramanian, E. Karshovska, P. Reinhard, R.T. Megens, Z. Zhou, S. Akhtar, U. Schumann, X. Li, M. van Zandvoort, C. Ludin, C. Weber, and A. Schober Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation Circ. Res. 107 2010 96 105
70. K.J. Herr, D.R. Herr, C.W. Lee, K. Noguchi, and J. Chun Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling Proc. Natl. Acad. Sci. U. S. A. 108 2011 15444 15449